Archon Biosciences is a startup based in the United States, most recent round Seed, 1 tracked investor.
Based in the United States, Archon Biosciences is a startup founded in 2024. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Archon Biosciences develops computationally designed Antibody Cages (AbCs), a novel class of biologics that leverage generative AI and protein design to target previously inaccessible therapeutic pathways.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.